Using this technique, metabolic profiles and biomarkers predicting long-term survival for locally advanced breast cancer [16], node involvement of patients with infiltrating ductal carcinoma [17], and 5-year survival for ER positive patients [18] have been identified. This evidence concerns the gene ESR1 and breast cancer.